Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

The Critical Role of Sample Storage in Drug Discovery and Development

Astoriom's CEO, Will Edwards, highlights the importance of biological sample management and storage stability in advancing drug discovery and development.

10 Nov 2026

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at its Suzhou, China R&D center is complete.

From ELDICO Scientific AG 10 Nov 2026

VA grant funds implantable stimulator to improve the lives of disabled veterans

With a $3.1 million grant from the U.S. Department of Veterans Affairs (VA), a Case Western Reserve University (CWRU) researcher's quest to transform the quality of life of people living with spinal cord injuries will move closer to a clinical trial.

9 Nov 2026

Metal fumes, drinking habits and dementia: What a new study found

This study examines how workplace chemicals and lifestyle habits may influence Lewy body dementia risk, revealing potential sex differences in exposure effects.

6 Nov 2026

MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, and Biocodex, an independent French pharmaceutical company with more than 70 years of experience in the microbiome field, today announced the launch of a strategic partnership to establish specialized manufacturing capabilities for live biotherapeutic products.

6 Nov 2026

Review examines translational bottlenecks for plant-derived anti-inflammatory compounds

A review led by Professor Weidong Zhang at the School of Pharmacy, Naval Medical University, was published in Volume 2 of the journal Immunity & Inflammation on October 27, 2026. The article systematically examines the translational bottlenecks and potential solutions for plant-derived anti-inflammatory compounds.

5 Nov 2026

CIRM grant funds new stem cell therapy to heal hearts

A new $6.9 million grant from the California Institute for Regenerative Medicine (CIRM) will support preclinical development of an investigational cell therapy for the heart created by USC Stem Cell scientists.

5 Nov 2026

Scientists develop slug-inspired hydrogel to seal gastrointestinal fistulas

Gastrointestinal fistulas are abnormal passages between the digestive tract and another organ or tissue. They are a common complication of surgery, trauma, inflammatory diseases, and malignant tumors and can be life-threatening in severe cases.

5 Nov 2026

UCLA advances CRISPR gene-editing therapy for sickle cell disease

A UCLA-led team has described how they advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

4 Nov 2026

1nhaler secures £2.2 million to continue late-stage development

The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.

3 Nov 2026

New hormone receptor strategy offers targeted treatment for lupus

Researchers at the University of California, Riverside and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues.

2 Nov 2026

FDA approves ILUMYA for adults with active psoriatic arthritis

Sun Pharmaceutical Industries Limited announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ILUMYA® (tildrakizumab-asmn) for the treatment of adults with active psoriatic arthritis (PsA).

30 Oct 2026

Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai

Dr. Jue Wang, Head of Global Business Development at Insilico Medicine, has been invited to attend the China Healthcare Summit in Shanghai. On the afternoon of November 3 at 16:45, she will deliver a keynote speech in the panel titled: "THE COMMODITIZATION TRAP: WHO WINS WHEN EVERYONE HAS THE SAME AI?"

30 Oct 2026

Discarded fruit and vegetable parts offer overlooked fiber benefits

Most of us routinely discard the peels, skins, stalks, and seeds of fruits and vegetables at mealtime. But new research from King's College London suggests these scraps could be a valuable – and overlooked – source of dietary fiber, offering potential benefits for both public health and the environment.

29 Oct 2026

Multivitamins boost key vitamin levels, but do they improve your health?

A scoping review of 157 clinical trial reports found that multivitamins consistently improved circulating levels of folate, vitamin B6, and vitamin B12, while other nutritional and clinical effects varied by formulation, population, and baseline nutritional status. Selected prenatal and cognitive outcomes improved in some trials, but evidence for cardiovascular disease prevention was largely negative, and the review could not establish the overall certainty of clinical benefits.

29 Oct 2026

Ancient Egyptian pigment inspires new bright brain imaging tool

For medical imaging, innovative contrast agents are in high demand. Materials scientist Robert Nissler has therefore developed an ultra-bright near-infrared nano-pigment designed to provide high-resolution images of intricate brain structures.

29 Oct 2026

Researchers find simple way to boost engineered T-cell therapies

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a promising new strategy to make cancer-fighting immune cells stronger and potentially longer-lasting, a discovery that could help improve the effectiveness of immunotherapies that use a patient's own immune cells to attack cancer.

29 Oct 2026

Revvity launches Signals LabGistics solution to connect and orchestrate scientific workflows

Revvity, Inc. announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

From Revvity Signals Software Inc. 29 Oct 2026

Bedfont® Scientific strengthens its commitment to respiratory clinical research

Bedfont® Scientific Limited, a world leader in breath analysis with 50 years of experience manufacturing medical devices, has quietly supported respiratory research around the world and is set to make its debut at its first clinical trial-focused event in November, taking the next step toward a dedicated focus on supporting clinical trials and clinical research teams, marking the beginning of a new chapter at Bedfont®.

From NObreath 29 Oct 2026

New portable device enables fast and accurate detection of PFAS in water

Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals known for their exceptional resistance to degradation, earning them the nickname "forever chemicals."

28 Oct 2026